Plastic Bronchitis and Protein Losing Enteropathy in Children With Single Ventricle Physiology
NCT01563757 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2013-10-29
Summary
The investigators are studying what causes Plastic Bronchitis and Protein Losing Enteropathy. The investigators think that these problems are from too much of two small proteins called Vasoactive Intestinal Peptide (VIP) and Substance P. VIP and Substance P are important proteins in the body that normally tell the body to make small amounts of fluid and they help the intestines work. Normally, VIP and Substance P are made in the intestines and then destroyed in the lungs after they do their normal work. The investigators think that kids who have Plastic Bronchitis and/or Protein Losing Enteropathy who also had the Fontan surgery might have too much VIP and Substance P in their bodies. The investigators think this causes too much fluid to go in the lungs and too much protein in the intestines.
Conditions
- Fontan Physiology Patients With PB or PLE
- Fontan Physiology Patients Without PB or PLE
Sponsors & Collaborators
-
Children's Hospital and Health System Foundation, Wisconsin
collaborator OTHER -
Medical College of Wisconsin
lead OTHER
Principal Investigators
-
Todd Gudausky, MD · Medical College of Wisconsin
-
Jake Scott, MD · Medical College of Wisconsin
-
William Clarke, MD, MS · Medical College of Wisconsin
Eligibility
- Min Age
- 6 Months
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-03-31
- Primary Completion
- 2013-09-30
- Completion
- 2013-09-30
Countries
- United States
Study Locations
More Related Trials
-
BPAP in Pediatric Asthma Pilot Study
NCT04656587 ·Status: WITHDRAWN ·Phase: NA
-
Effect of Palivizumab on Later Recurrent Wheezing in Preterm Infants
NCT01072552 ·Status: COMPLETED
-
Cellular Therapy for Extreme Preterm Infants at Risk of Developing Bronchopulmonary Dysplasia
NCT04255147 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
PK, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With Developing Bronchopulmonary Dysplasia
NCT07101640 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Little Lungs Study
NCT06855043 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF)
NCT01467076 ·Status: TERMINATED ·Phase: PHASE2
-
Airway Inflammation in Congenital Diaphragmatic Hernia Patients
NCT02453750 ·Status: COMPLETED ·Phase: NA
-
Dornase Alfa Therapy for Ventilator Associated Lung Infections in the Neonatal Intensive Care Unit (NICU)
NCT01356147 ·Status: COMPLETED ·Phase: PHASE4
-
Implementation of a Consensus-Based Discharge Protocol for Preterm Infants With Lung Disease
NCT05285345 ·Status: RECRUITING
-
Prone Position Effects on Work of Breathing and Intrinsic PEEP in Children With Severe Acute Viral Bronchiolitis
NCT02602678 ·Status: COMPLETED ·Phase: NA
-
Acute Effects of Inhaled Treprostinil in Fontan Patients
NCT02769624 ·Status: TERMINATED ·Phase: PHASE2
-
Integrated Pulmonary Index (IPI) as a Determinate of Weaning Success and/or Failure in the Pediatric Population
NCT01795196 ·Status: WITHDRAWN
-
Follow-Up Study of Mesenchymal Stem Cells for Bronchopulmonary Dysplasia
NCT03873506 ·Status: UNKNOWN ·Phase: PHASE1
-
A Pilot Study of Pulmonary Function in Dysphagic Infants
NCT00831038 ·Status: COMPLETED ·Phase: NA
-
Surfactant Nebulization for the Early Aeration of the Preterm Lung
NCT04315636 ·Status: COMPLETED ·Phase: PHASE3
-
Inhaled Beclomethasone to Prevent Chronic Lung Disease
NCT00000576 ·Status: COMPLETED ·Phase: PHASE3
-
Human Mesenchymal Stem Cells For Infants At High Risk For Bronchopulmonary Dysplasia
NCT03774537 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Human Mesenchymal Stem Cells For Moderate and Severe Bronchopulmonary Dysplasia
NCT03601416 ·Status: UNKNOWN ·Phase: PHASE2
-
Pediatric Intensive Care Ulcer Prophylaxis Pilot Trial
NCT02929563 ·Status: COMPLETED ·Phase: PHASE3
-
Fluid Filled Lung Oxygenation Assistance Trial
NCT03041740 ·Status: COMPLETED ·Phase: PHASE1
-
Pediatric Bronchiolitis Quality Improvement
NCT03528083 ·Status: COMPLETED ·Phase: NA
-
Treatment of Pediatric Bronchiolitis Obliterans by Airway Basal Stem Cells
NCT07239895 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Saline Hypertonic in Preschoolers
NCT02378467 ·Status: COMPLETED ·Phase: NA
-
The Efficacy and Safety of Montelukast Sodium in the Prevention of Bronchopulmonary Dysplasia
NCT01717625 ·Status: COMPLETED ·Phase: PHASE2
-
Preterm Lung Patient Registry
NCT00951366 ·Status: RECRUITING